Loading...
Target Corporation
0LD8.L•LSE
Consumer CyclicalSpecialty Retail
£96.90
£2.85(3.03%)
Target Corporation (0LD8.L) Financial Performance & Statements
Review Target Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.79%
↓ 0.79%
Operating Income Growth
-2.47%
↓ 2.47%
Net Income Growth
-1.14%
↓ 1.14%
Operating Cash Flow Growth
-14.55%
↓ 14.55%
Operating Margin
5.42%
↑ 5.42%
Gross Margin
22.29%
↑ 22.29%
Net Profit Margin
3.95%
↑ 3.95%
ROE
28.60%
↑ 28.60%
ROIC
15.44%
↑ 15.44%
Target Corporation (0LD8.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Target Corporation stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $30.91B | $25.67B | $25.45B | $24.53B |
Cost of Revenue | $22.88B | $17.76B | $17.80B | $18.07B |
Gross Profit | $8.04B | $7.91B | $7.65B | $6.46B |
Gross Profit Ratio | $0.28 | $0.31 | $0.30 | $0.26 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $5.92B | $5.49B | $5.39B | $5.17B |
Operating Expenses | $7.83B | $5.49B | $6.02B | $5.17B |
Total Costs & Expenses | $30.70B | $23.24B | $23.82B | $23.23B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $90.00M | $105.00M | $110.00M | $106.00M |
Depreciation & Amortization | $106.00M | $1.46B | $743.00M | $718.00M |
EBITDA | $1.60B | $2.66B | $2.40B | $2.04B |
EBITDA Ratio | $0.05 | -$0.01 | $0.10 | $0.08 |
Operating Income | $210.00M | $2.42B | $1.64B | $1.30B |
Operating Income Ratio | $0.05 | $0.05 | $0.06 | $0.05 |
Other Income/Expenses (Net) | $1.20B | -$1.33B | -$90.00M | -$77.00M |
Income Before Tax | $1.41B | $1.09B | $1.54B | $1.22B |
Income Before Tax Ratio | $0.05 | $0.04 | $0.06 | $0.05 |
Income Tax Expense | $303.00M | $237.00M | $353.00M | $277.00M |
Net Income | $1.10B | $854.00M | $1.19B | $942.00M |
Net Income Ratio | $0.04 | $0.03 | $0.05 | $0.04 |
EPS | $2.42 | $1.85 | $2.58 | $2.04 |
Diluted EPS | $2.42 | $1.84 | $2.57 | $2.03 |
Weighted Avg Shares Outstanding | $460.40M | $461.60M | $462.50M | $462.20M |
Weighted Avg Shares Outstanding (Diluted) | $461.80M | $462.90M | $463.50M | $463.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan